Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Stroke

  Free Subscription


Articles published in Am J Cardiol

Retrieve available abstracts of 121 articles:
HTML format
Text format



Single Articles


    April 2019
  1. SHIBUYA J, Kobayashi N, Asai K, Tsurumi M, et al
    Comparison of Coronary Culprit Lesion Morphology Determined by Optical Coherence Tomography and Relation to Outcomes in Patients Diagnosed with Acute Coronary Syndrome During Winter -vs- Other Seasons.
    Am J Cardiol. 2019 Apr 8. pii: S0002-9149(19)30410.
    PubMed     Text format     Abstract available


    January 2019
  2. NAZIR S, Elgin E, Loynd R, Zaman M, et al
    ST-Elevation Myocardial Infarction Associated With Infective Endocarditis.
    Am J Cardiol. 2019 Jan 31. pii: S0002-9149(19)30125.
    PubMed     Text format     Abstract available


  3. ZABCZYK M, Meus R, Malinowski KP, Natorska J, et al
    A Prothrombotic State in Patients With a History of Left Ventricular Thrombus.
    Am J Cardiol. 2019 Jan 24. pii: S0002-9149(19)30099.
    PubMed     Text format     Abstract available


  4. BANGALORE S, Schwamm LH, Smith EE, Hellkamp AS, et al
    Relation of Admission Blood Pressure to In-hospital and 90-Day Outcomes in Patients Presenting With Transient Ischemic Attack.
    Am J Cardiol. 2019 Jan 11. pii: S0002-9149(19)30040.
    PubMed     Text format     Abstract available


    September 2018
  5. KORJIAN S, Braunwald E, Daaboul Y, Mi M, et al
    Usefulness of Rivaroxaban for Secondary Prevention of Acute Coronary Syndrome in Patients With History of Congestive Heart Failure (from the ATLAS-ACS-2 TIMI-51 Trial).
    Am J Cardiol. 2018 Sep 7. pii: S0002-9149(18)31733.
    PubMed     Text format     Abstract available


    May 2018
  6. YESIN M, Karakoyun S, Kalcik M, Gursoy MO, et al
    Status of the Epicardial Coronary Arteries in Non-ST Elevation Acute Coronary Syndrome in Patients with Mechanical Prosthetic Heart Valves (from the TROIA-ACS Trial).
    Am J Cardiol. 2018 May 11. pii: S0002-9149(18)31046.
    PubMed     Text format     Abstract available


    April 2018
  7. NEUPANE S, Singh H, Lammer J, Othman H, et al
    Meta-Analysis of Transcatheter Valve-in-Valve Implantation Versus Redo Aortic Valve Surgery for Bioprosthetic Aortic Valve Dysfunction.
    Am J Cardiol. 2018 Apr 19. pii: S0002-9149(18)30290.
    PubMed     Text format     Abstract available


  8. SORIGUE M, Sarrate E, Franch-Sarto M, Sancho JM, et al
    Risk of Cardioembolic Stroke in Patients With Cancer and Atrial Fibrillation.
    Am J Cardiol. 2018 Apr 18. pii: S0002-9149(18)30296.
    PubMed     Text format    


    March 2018
  9. SLIVNICK JA, Yeow RY, McMahon C, Paje DG, et al
    Current Trends in Anticoagulation Bridging for Patients With Chronic Atrial Fibrillation on Warfarin Undergoing Endoscopy.
    Am J Cardiol. 2018 Mar 16. pii: S0002-9149(18)30279.
    PubMed     Text format     Abstract available


  10. VENDRIK J, van Mourik MS, van Kesteren F, Henstra MJ, et al
    Comparison of Outcomes of Transfemoral Aortic Valve Implantation in Patients <90 With Those >90 Years of Age.
    Am J Cardiol. 2018 Mar 15. pii: S0002-9149(18)30292.
    PubMed     Text format     Abstract available


  11. LEE OH, Kim JS, Pak HN, Hong GR, et al
    Feasibility of Left Atrial Appendage Occlusion for Left Atrial Appendage Thrombus in Patients With Persistent Atrial Fibrillation.
    Am J Cardiol. 2018 Mar 14. pii: S0002-9149(18)30281.
    PubMed     Text format     Abstract available


  12. ABUBAKAR H, Yassin AS, Akintoye E, Bakhit K, et al
    Financial Implications and Impact of Pre-existing Atrial Fibrillation on In-Hospital Outcomes in Patients Who Underwent Transcatheter Aortic Valve Implantation (from the National Inpatient Database).
    Am J Cardiol. 2018 Mar 14. pii: S0002-9149(18)30288.
    PubMed     Text format     Abstract available


  13. SRIVASTAVA P, Butler J, Shroyer AL, Lacey M, et al
    Impact of Depressive Disorder on Access and Quality of Care in Veterans With Prevalent Cardiovascular Disease.
    Am J Cardiol. 2018 Mar 14. pii: S0002-9149(18)30284.
    PubMed     Text format     Abstract available


  14. DUDEK D, Ebner A, Sobczynski R, Trebacz J, et al
    Efficacy and Safety of the HeartMate Percutaneous Heart Pump During High-Risk Percutaneous Coronary Intervention (from the SHIELD I Trial).
    Am J Cardiol. 2018 Mar 13. pii: S0002-9149(18)30282.
    PubMed     Text format     Abstract available


  15. NAGANUMA T, Tsujita K, Mitomo S, Ishiguro H, et al
    Impact of Chronic Kidney Disease on Outcomes After Percutaneous Coronary Intervention for Chronic Total Occlusions (from the Japanese Multicenter Registry).
    Am J Cardiol. 2018 Mar 13. pii: S0002-9149(18)30268.
    PubMed     Text format     Abstract available


  16. ITO S, Watanabe H, Morimoto T, Yoshikawa Y, et al
    Impact of Baseline Thrombocytopenia on Bleeding and Mortality After Percutaneous Coronary Intervention.
    Am J Cardiol. 2018 Mar 1. pii: S0002-9149(18)30245.
    PubMed     Text format     Abstract available


    January 2018
  17. SORIGUE M, Sarrate E, Franch-Sarto M, Santos-Gomez M, et al
    Anticoagulant Agents for Atrial Fibrillation in Cancer Patients.
    Am J Cardiol. 2018 Jan 31. pii: S0002-9149(18)30107.
    PubMed     Text format    


  18. HIZOH I, Banhegyi G, Domokos D, Gulyas Z, et al
    Impact of Selective Aspiration Thrombectomy on Mortality in Patients With ST-Segment Elevation Myocardial Infarction.
    Am J Cardiol. 2018 Jan 10. pii: S0002-9149(18)30053.
    PubMed     Text format     Abstract available


  19. HUSSAIN N, Gersh BJ, Gonzalez Carta K, Sydo N, et al
    Impact of Cardiorespiratory Fitness on Frequency of Atrial Fibrillation, Stroke, and All-Cause Mortality.
    Am J Cardiol. 2018;121:41-49.
    PubMed     Text format     Abstract available


  20. STONE J, Mor-Avi V, Ardelt A, Lang RM, et al
    Frequency of Inverted Electrocardiographic T Waves (Cerebral T Waves) in Patients With Acute Strokes and Their Relation to Left Ventricular Wall Motion Abnormalities.
    Am J Cardiol. 2018;121:120-124.
    PubMed     Text format     Abstract available


    December 2017
  21. ELBADAWI A, Elgendy IY, Ha LD, Baig B, et al
    In-Hospital Cerebrovascular Outcomes of Patients With Atrial Fibrillation and Cancer (from the National Inpatient Sample Database).
    Am J Cardiol. 2017 Dec 20. pii: S0002-9149(17)31852.
    PubMed     Text format     Abstract available


  22. BISSON A, Bodin A, Clementy N, Babuty D, et al
    Prediction of Incident Atrial Fibrillation According to Gender in Patients With Ischemic Stroke From a Nationwide Cohort.
    Am J Cardiol. 2017 Dec 2. pii: S0002-9149(17)31774.
    PubMed     Text format     Abstract available


    November 2017
  23. LEE CH, Lee JY, Park GM, Lee SW, et al
    Comparison of 1-Year Outcomes of Triple (Aspirin + Clopidogrel + Cilostazol) Versus Dual Antiplatelet Therapy (Aspirin + Clopidogrel + Placebo) After Implantation of Second-Generation Drug-Eluting Stents into One or More Coronary Arteries: from the DE
    Am J Cardiol. 2017 Nov 24. pii: S0002-9149(17)31763.
    PubMed     Text format     Abstract available


  24. LIP GYH, Merino JL, Dan GA, Themistoclakis S, et al
    Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of Edoxaban for Cardioversion of Atrial Fibrillation (from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation [ENSURE-AF] Study).
    Am J Cardiol. 2017 Nov 20. pii: S0002-9149(17)31616.
    PubMed     Text format     Abstract available


    October 2017
  25. KUMAR N, Khera R, Garg N, Echouffo-Tcheugui JB, et al
    Comparison of Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Chronic Kidney Disease.
    Am J Cardiol. 2017 Oct 31. pii: S0002-9149(17)31686.
    PubMed     Text format     Abstract available


  26. ORVIN K, Levi A, Landes U, Bental T, et al
    Usefulness of the CHA2DS2-VASc Score to Predict Outcome in Patients Who Underwent Transcatheter Aortic Valve Implantation.
    Am J Cardiol. 2017 Oct 19. pii: S0002-9149(17)31620.
    PubMed     Text format     Abstract available


  27. GARG PK, O'Neal WT, Ogunsua A, Thacker EL, et al
    Usefulness of the American Heart Association's Life Simple 7 to Predict the Risk of Atrial Fibrillation (from the REasons for Geographic And Racial Differences in Stroke [REGARDS] Study).
    Am J Cardiol. 2017 Oct 19. pii: S0002-9149(17)31615.
    PubMed     Text format     Abstract available


  28. NISHIMURA M, Hsu JC
    Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and End-Stage Renal Disease.
    Am J Cardiol. 2017 Oct 12. pii: S0002-9149(17)31602.
    PubMed     Text format     Abstract available


  29. JAKOBSEN L, Terkelsen CJ, Sondergaard L, Backer OD, et al
    Short- and Long-Term Mortality and Stroke Risk After Transcatheter Aortic Valve Implantation.
    Am J Cardiol. 2017 Oct 10. pii: S0002-9149(17)31586.
    PubMed     Text format     Abstract available


    September 2017
  30. PATELL R, Gutierrez A, Rybicki L, Khorana AA, et al
    Usefulness of CHADS2 and CHA2DS2-VASc Scores for Stroke Prediction in Patients With Cancer and Atrial Fibrillation.
    Am J Cardiol. 2017 Sep 20. pii: S0002-9149(17)31457.
    PubMed     Text format     Abstract available


    August 2017
  31. WANDELL P, Carlsson AC, Holzmann MJ, Arnlov J, et al
    Comparison of Mortality and Nonfatal Cardiovascular Events in Adults With Atrial Fibrillation With Versus Without Levothyroxine Treatment.
    Am J Cardiol. 2017 Aug 30. pii: S0002-9149(17)31383.
    PubMed     Text format     Abstract available


  32. DURHAM TA, Hassmiller Lich K, Viera AJ, Fine JP, et al
    Utilization of Standard and Target-Specific Oral Anticoagulants Among Adults in the United Kingdom With Incident Atrial Fibrillation.
    Am J Cardiol. 2017 Aug 12. pii: S0002-9149(17)31297.
    PubMed     Text format     Abstract available


  33. KOSMIDOU I, Embacher M, McAndrew T, Dizon JM, et al
    Early Ventricular Tachycardia or Fibrillation in Patients With ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention and Impact on Mortality and Stent Thrombosis (from the Harmonizing Outcomes with Revascularization
    Am J Cardiol. 2017 Aug 8. pii: S0002-9149(17)31286.
    PubMed     Text format     Abstract available


  34. ELGENDY AY, Mahtta D, Barakat AF, Abuzaid A, et al
    Meta-Analysis of Safety and Efficacy of Uninterrupted Non-Vitamin K Antagonist Oral Anticoagulants Versus Vitamin K Antagonists for Catheter Ablation of Atrial Fibrillation.
    Am J Cardiol. 2017 Aug 8. pii: S0002-9149(17)31302.
    PubMed     Text format     Abstract available


  35. HERNANDEZ I, Zhang Y, Saba S
    Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Newly Diagnosed Atrial Fibrillation.
    Am J Cardiol. 2017 Aug 8. pii: S0002-9149(17)31298.
    PubMed     Text format     Abstract available


  36. CHEN ST, Hellkamp AS, Becker RC, Berkowitz SD, et al
    Outcome of Patients Receiving Thrombolytic Therapy While on Rivaroxaban for Nonvalvular Atrial Fibrillation (from Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in
    Am J Cardiol. 2017 Aug 7. pii: S0002-9149(17)31301.
    PubMed     Text format     Abstract available


  37. BAI Y, Shi XB, Ma CS, Lip GYH, et al
    Meta-Analysis of Effectiveness and Safety of Oral Anticoagulants in Atrial Fibrillation With Focus on Apixaban.
    Am J Cardiol. 2017 Aug 1. pii: S0002-9149(17)31245.
    PubMed     Text format     Abstract available


    July 2017
  38. SHANTHA GPS, Mentias A, Bhise V, Kumar A, et al
    Gender Differences in the Trends of Hospitalizations for Acute Stroke Among Patients With Atrial Fibrillation in the United States: 2005 to 2014.
    Am J Cardiol. 2017 Jul 31. pii: S0002-9149(17)31217.
    PubMed     Text format     Abstract available


  39. LIU T, Hui J, Hou YY, Zou Y, et al
    Meta-Analysis of Efficacy and Safety of Low-Intensity Warfarin Therapy for East Asian Patients With Nonvalvular Atrial Fibrillation.
    Am J Cardiol. 2017 Jul 31. pii: S0002-9149(17)31223.
    PubMed     Text format     Abstract available


  40. YAO X, Gersh BJ, Sangaralingham LR, Kent DM, et al
    Comparison of the CHA2DS2-VASc, CHADS2, HAS-BLED, ORBIT, and ATRIA Risk Scores in Predicting Non-Vitamin K Antagonist Oral Anticoagulants-Associated Bleeding in Patients With Atrial Fibrillation.
    Am J Cardiol. 2017 Jul 31. pii: S0002-9149(17)31224.
    PubMed     Text format     Abstract available


  41. CARROLL BJ, Pemberton H, Bauer KA, Chu LM, et al
    Initiation of a Multidisciplinary, Rapid Response Team to Massive and Submassive Pulmonary Embolism.
    Am J Cardiol. 2017 Jul 26. pii: S0002-9149(17)31198.
    PubMed     Text format     Abstract available


  42. KHURSHID S, Weng LC, Hulme OL, Ellinor PT, et al
    Factors Associated with Anticoagulation Delay Following New-Onset Atrial Fibrillation.
    Am J Cardiol. 2017 Jul 24. pii: S0002-9149(17)31181.
    PubMed     Text format     Abstract available


  43. WIESEL J, Salomone TJ
    Screening for Atrial Fibrillation in Patients >/=65 Years Using an Automatic Blood Pressure Monitor in a Skilled Nursing Facility.
    Am J Cardiol. 2017 Jul 24. pii: S0002-9149(17)31180.
    PubMed     Text format     Abstract available


  44. SOLIMAN EZ, Zhang ZM, Judd S, Howard VJ, et al
    Comparison of Risk of Atrial Fibrillation Among Employed Versus Unemployed (from the REasons for Geographic and Racial Differences in Stroke Study).
    Am J Cardiol. 2017 Jul 21. pii: S0002-9149(17)31165.
    PubMed     Text format     Abstract available


  45. LOIKAS D, Forslund T, Wettermark B, Schenck-Gustafsson K, et al
    Sex and Gender Differences in Thromboprophylactic Treatment of Patients With Atrial Fibrillation After the Introduction of Non-Vitamin K Oral Anticoagulants.
    Am J Cardiol. 2017 Jul 21. pii: S0002-9149(17)31166.
    PubMed     Text format     Abstract available


  46. ADMASSIE E, Chalmers L, Bereznicki LR
    Changes in Oral Anticoagulant Prescribing for Stroke Prevention in Patients With Atrial Fibrillation.
    Am J Cardiol. 2017 Jul 14. pii: S0002-9149(17)31117.
    PubMed     Text format     Abstract available


  47. HONG C, Alluri K, Shariff N, Khattak F, et al
    Usefulness of the CHA2DS2-VASc Score to Predict Mortality in Defibrillator Recipients.
    Am J Cardiol. 2017;120:83-86.
    PubMed     Text format     Abstract available


    June 2017
  48. LIP GYH, Al-Saady N, Jin J, Sun M, et al
    Anticoagulation Control in Warfarin-Treated Patients Undergoing Cardioversion of Atrial Fibrillation (from the Edoxaban Versus Enoxaparin-Warfarin in Patients Undergoing Cardioversion of Atrial Fibrillation Trial).
    Am J Cardiol. 2017 Jun 15. pii: S0002-9149(17)30957.
    PubMed     Text format     Abstract available


  49. ASHBURNER JM, Singer DE, Lubitz SA, Borowsky LH, et al
    Changes in Use of Anticoagulation in Patients With Atrial Fibrillation Within a Primary Care Network Associated With the Introduction of Direct Oral Anticoagulants.
    Am J Cardiol. 2017 Jun 15. pii: S0002-9149(17)30956.
    PubMed     Text format     Abstract available


  50. SILBERBERG A, Tan MK, Yan AT, Angaran P, et al
    Use of Evidence-Based Therapy for Cardiovascular Risk Factors in Canadian Outpatients With Atrial Fibrillation: From the Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation (FREEDOM AF) and Co-ordinated National Netw
    Am J Cardiol. 2017 Jun 1. pii: S0002-9149(17)30863.
    PubMed     Text format     Abstract available


    May 2017
  51. WASHAM JB, Hellkamp AS, Lokhnygina Y, Piccini JP, et al
    Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial).
    Am J Cardiol. 2017 May 29. pii: S0002-9149(17)30862.
    PubMed     Text format     Abstract available


  52. LEMPEREUR M, Aminian A, Freixa X, Gafoor S, et al
    Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Previous Major Gastrointestinal Bleeding (from the Amplatzer Cardiac Plug Multicenter Registry).
    Am J Cardiol. 2017 May 12. pii: S0002-9149(17)30782.
    PubMed     Text format     Abstract available


  53. SHAH RR, Pillai A, Schafer P, Meggo D, et al
    Safety and Efficacy of Uninterrupted Apixaban Therapy Versus Warfarin During Atrial Fibrillation Ablation.
    Am J Cardiol. 2017 May 10. pii: S0002-9149(17)30777.
    PubMed     Text format     Abstract available


  54. DE ASMUNDIS C, Mugnai G, Chierchia GB, Sieira J, et al
    Long-Term Follow-Up of Probands With Brugada Syndrome.
    Am J Cardiol. 2017;119:1392-1400.
    PubMed     Text format     Abstract available


  55. LEE MS, Park KW, Shlofmitz E, Shlofmitz RA, et al
    Comparison of Rotational Atherectomy Versus Orbital Atherectomy for the Treatment of Heavily Calcified Coronary Plaques.
    Am J Cardiol. 2017;119:1320-1323.
    PubMed     Text format     Abstract available


    April 2017
  56. LAUBE ES, Yu A, Gupta D, Miao Y, et al
    Rivaroxaban for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation and Active Cancer.
    Am J Cardiol. 2017 Apr 27. pii: S0002-9149(17)30697.
    PubMed     Text format     Abstract available


  57. MUGNAI G, de Asmundis C, Iacopino S, Stroker E, et al
    Comparison of the Incidences of Complications After Second-Generation Cryoballoon Ablation of Atrial Fibrillation Using Vitamin K Antagonists Versus Novel Oral Anticoagulants.
    Am J Cardiol. 2017 Apr 27. pii: S0002-9149(17)30700.
    PubMed     Text format     Abstract available


  58. DE HARO J, Michel I, Bleda S, Canibano C, et al
    Carotid Stenting in Patients With High Risk Versus Standard Risk for Open Carotid Endarterectomy (REAL-1 Trial).
    Am J Cardiol. 2017 Apr 26. pii: S0002-9149(17)30711.
    PubMed     Text format     Abstract available


  59. GOLIVE A, May HT, Bair TL, Jacobs V, et al
    The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial Fibrillation.
    Am J Cardiol. 2017 Apr 12. pii: S0002-9149(17)30627.
    PubMed     Text format     Abstract available


    March 2017
  60. AGARWAL S, Sud K, Thakkar B, Menon V, et al
    Changing Trends of Atherosclerotic Risk Factors Among Patients With Acute Myocardial Infarction and Acute Ischemic Stroke.
    Am J Cardiol. 2017 Mar 31. pii: S0002-9149(17)30213.
    PubMed     Text format     Abstract available


  61. VELASQUEZ-RODRIGUEZ J, Diez-Delhoyo F, Valero-Masa MJ, Vicent L, et al
    Prognostic Impact of Age and Hemoglobin in Acute ST-Segment Elevation Myocardial Infarction Treated With Reperfusion Therapy.
    Am J Cardiol. 2017 Mar 29. pii: S0002-9149(17)30341.
    PubMed     Text format     Abstract available


  62. BALLA SR, Cyr DD, Lokhnygina Y, Becker RC, et al
    Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index (from Patients Treated With Rivaroxaban and Warfarin in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of
    Am J Cardiol. 2017 Mar 29. pii: S0002-9149(17)30352.
    PubMed     Text format     Abstract available


  63. NGUYEN P, Kamran H, Nasir S, Chan W, et al
    Comparison of Frequency of Cardiovascular Events and Mortality in Patients With Heart Failure Using Versus Not Using Cocaine.
    Am J Cardiol. 2017 Mar 29. pii: S0002-9149(17)30358.
    PubMed     Text format     Abstract available


  64. ELBADAWI A, Olorunfemi O, Ogunbayo GO, Saad M, et al
    Cardiovascular Outcomes With Surgical Left Atrial Appendage Exclusion in Patients With Atrial Fibrillation Who Underwent Valvular Heart Surgery (from the National Inpatient Sample Database).
    Am J Cardiol. 2017 Mar 29. pii: S0002-9149(17)30361.
    PubMed     Text format     Abstract available


  65. STEINBERG BA, Simon DN, Thomas L, Ansell J, et al
    Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fib
    Am J Cardiol. 2017 Mar 28. pii: S0002-9149(17)30201.
    PubMed     Text format     Abstract available


  66. CHERIAN TS, Shrader P, Fonarow GC, Allen LA, et al
    Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).
    Am J Cardiol. 2017 Mar 16. pii: S0002-9149(17)30289.
    PubMed     Text format     Abstract available


  67. O'NEAL WT, Sandesara P, Hammadah M, Venkatesh S, et al
    Gender Differences in the Risk of Adverse Outcomes in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction.
    Am J Cardiol. 2017 Mar 16. pii: S0002-9149(17)30282.
    PubMed     Text format     Abstract available


  68. BOSE A, O'Neal WT, Bennett A, Judd SE, et al
    Relation Between Estimated Cardiorespiratory Fitness and Atrial Fibrillation (from the Reasons for Geographic and Racial Differences in Stroke Study).
    Am J Cardiol. 2017 Mar 16. pii: S0002-9149(17)30285.
    PubMed     Text format     Abstract available


    February 2017
  69. XIE JX, Glorioso TJ, Dattilo PB, Aggarwal V, et al
    Effect of Chronic Kidney Disease on Mortality in Patients Who Underwent Lower Extremity Peripheral Vascular Intervention.
    Am J Cardiol. 2017;119:669-674.
    PubMed     Text format     Abstract available


  70. BYKOV K, Schneeweiss S, Donneyong MM, Dong YH, et al
    Impact of an Interaction Between Clopidogrel and Selective Serotonin Reuptake Inhibitors.
    Am J Cardiol. 2017;119:651-657.
    PubMed     Text format     Abstract available


  71. QIAN C, Feng H, Cao J, Wei B, et al
    Meta-Analysis of Randomized Control Trials Comparing Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Significant Left Main Coronary Narrowing.
    Am J Cardiol. 2017 Feb 10. pii: S0002-9149(17)30126.
    PubMed     Text format     Abstract available


  72. DIDIER R, Gaglia MA Jr, Lipinski MJ, Koifman E, et al
    Comparison of Baseline Characteristics and Inhospital Outcomes of Patients and Use of Bare Metal Versus Drug-Eluting Stents During Percutaneous Coronary Intervention 2005 to 2015 at a Single Tertiary Hospital.
    Am J Cardiol. 2017 Feb 9. pii: S0002-9149(17)30115.
    PubMed     Text format     Abstract available


    January 2017
  73. POLI D, Antonucci E, Pengo V, Testa S, et al
    Comparison of HAS-BLED and HAS-BED Versus CHADS2 and CHA2DS2VASC Stroke and Bleeding Scores in Patients With Atrial Fibrillation.
    Am J Cardiol. 2017 Jan 26. pii: S0002-9149(16)32003.
    PubMed     Text format     Abstract available


  74. ABE M, Ogawa H, Ishii M, Masunaga N, et al
    Relation of Stroke and Major Bleeding to Creatinine Clearance in Patients With Atrial Fibrillation (from the Fushimi AF Registry).
    Am J Cardiol. 2017 Jan 25. pii: S0002-9149(17)30054.
    PubMed     Text format     Abstract available


  75. COHEN R, Bavishi C, Haider S, Thankachen J, et al
    Meta-Analysis of Relation of Vital Exhaustion to Cardiovascular Disease Events.
    Am J Cardiol. 2017 Jan 25. pii: S0002-9149(17)30067.
    PubMed     Text format     Abstract available


  76. QI Z, Chen H, Wen Z, Yuan F, et al
    Relation of Low-Density Lipoprotein Cholesterol to Ischemic Stroke in Patients With Nonvalvular Atrial Fibrillation.
    Am J Cardiol. 2017 Jan 25. pii: S0002-9149(17)30055.
    PubMed     Text format     Abstract available


  77. SHERAZI S, Kutyifa V, McNitt S, Papernov A, et al
    Effect of Gender on the Risk of Neurologic Events and Subsequent Outcomes in Patients With Left Ventricular Assist Devices.
    Am J Cardiol. 2017;119:297-301.
    PubMed     Text format     Abstract available


  78. MUSCARI A, Bonfiglioli A, Faccioli L, Ghinelli M, et al
    Usefulness of the MrWALLETS Scoring System to Predict First Diagnosed Atrial Fibrillation in Patients With Ischemic Stroke.
    Am J Cardiol. 2017 Jan 5. pii: S0002-9149(16)32005.
    PubMed     Text format     Abstract available


    December 2016
  79. NORTON L, Tsiperfal A, Cook K, Bagdasarian A, et al
    Effectiveness and Safety of an Independently Run Nurse Practitioner Outpatient Cardioversion Program (2009 to 2014).
    Am J Cardiol. 2016;118:1842-1846.
    PubMed     Text format     Abstract available


  80. FREIXA X, Llull L, Gafoor S, Cruz-Gonzalez I, et al
    Characterization of Cerebrovascular Events After Left Atrial Appendage Occlusion.
    Am J Cardiol. 2016;118:1836-1841.
    PubMed     Text format     Abstract available


  81. JONES PH, Bays HE, Chaudhari U, Pordy R, et al
    Safety of Alirocumab (A PCSK9 Monoclonal Antibody) from 14 Randomized Trials.
    Am J Cardiol. 2016;118:1805-1811.
    PubMed     Text format     Abstract available


  82. PEACOCK WF, Tamayo S, Sicignano N, Hopf KP, et al
    Comparison of the Incidence of Major Bleeding With Rivaroxaban Use Among Nonvalvular Atrial Fibrillation Patients With Versus Without Diabetes Mellitus.
    Am J Cardiol. 2016 Dec 9. pii: S0002-9149(16)31892.
    PubMed     Text format     Abstract available


  83. BRASCIA D, Reichart D, Onorati F, Perrotti A, et al
    Validation of Bleeding Classifications in Coronary Artery Bypass Grafting.
    Am J Cardiol. 2016 Dec 3. pii: S0002-9149(16)31896.
    PubMed     Text format     Abstract available


  84. LIP GY, Waldo AL, Ip J, Martin DT, et al
    Determinants of Time in Therapeutic Range in Patients Receiving Oral Anticoagulants (A Substudy of IMPACT).
    Am J Cardiol. 2016;118:1680-1684.
    PubMed     Text format     Abstract available


    November 2016
  85. GUO L, Li S, Wang P, Zhong X, et al
    Comparative Efficacy of Clinical Events Prevention of Five Anticoagulants in Patients With Atrial Fibrillation (A Network Meta-Analysis).
    Am J Cardiol. 2016 Nov 16. pii: S0002-9149(16)31817.
    PubMed     Text format     Abstract available


  86. SUN Y, Liu X, He Y, Tang M, et al
    Meta-Analysis of Impact of Diabetes Mellitus on Outcomes After Transcatheter Aortic Valve Implantation.
    Am J Cardiol. 2016 Nov 16. pii: S0002-9149(16)31824.
    PubMed     Text format     Abstract available


  87. BANGALORE S, Fayyad R, Messerli FH, Laskey R, et al
    Relation of Variability of Low-Density Lipoprotein Cholesterol and Blood Pressure to Events in Patients With Previous Myocardial Infarction from the IDEAL Trial.
    Am J Cardiol. 2016 Nov 4. pii: S0002-9149(16)31749.
    PubMed     Text format     Abstract available


  88. KARUNANITHI Z, Nyboe C, Hjortdal VE
    Long-Term Risk of Atrial Fibrillation and Stroke in Patients With Atrial Septal Defect Diagnosed in Childhood.
    Am J Cardiol. 2016 Nov 1. pii: S0002-9149(16)31726.
    PubMed     Text format     Abstract available


  89. GARG L, Agrawal S, Pew T, Hanzel GS, et al
    Psoas Muscle Area as a Predictor of Outcomes in Transcatheter Aortic Valve Implantation.
    Am J Cardiol. 2016 Nov 1. pii: S0002-9149(16)31730.
    PubMed     Text format     Abstract available


    October 2016
  90. OHYA M, Kadota K, Toyofuku M, Morimoto T, et al
    Long-Term Outcomes After Stent Implantation for Left Main Coronary Artery (from the Multicenter Assessing Optimal Percutaneous Coronary Intervention for Left Main Coronary Artery Stenting Registry).
    Am J Cardiol. 2016 Oct 31. pii: S0002-9149(16)31744.
    PubMed     Text format     Abstract available


  91. BENJAMIN MM, Chaddha A, Sampene E, Field ME, et al
    Comparison of Outcomes of Atrial Fibrillation in Patients With Reduced Versus Preserved Left Ventricular Ejection Fraction.
    Am J Cardiol. 2016 Oct 11. pii: S0002-9149(16)31489.
    PubMed     Text format     Abstract available


  92. MARTIN RC, Burgin WS, Schabath MB, Kirby B, et al
    Gender-Specific Differences for Risk of Disability and Death in Atrial Fibrillation-Related Stroke.
    Am J Cardiol. 2016 Oct 8. pii: S0002-9149(16)31621.
    PubMed     Text format     Abstract available


  93. HELLYER JA, Azarbal F, Than CT, Fan J, et al
    Impact of Baseline Stroke Risk and Bleeding Risk on Warfarin International Normalized Ratio Control in Atrial Fibrillation (from the TREAT-AF Study).
    Am J Cardiol. 2016 Oct 8. pii: S0002-9149(16)31617.
    PubMed     Text format     Abstract available


  94. MOREYRA AE, Maniatis GA, Gu H, Swerdel JN, et al
    Frequency of Stroke After Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting (from an Eleven-Year Statewide Analysis).
    Am J Cardiol. 2016 Oct 8. pii: S0002-9149(16)31618.
    PubMed     Text format     Abstract available


    September 2016
  95. VARMDAL T, Janszky I, Bakken IJ, Ellekjaer H, et al
    Percutaneous Coronary Intervention as a Trigger for Stroke.
    Am J Cardiol. 2016 Sep 29. pii: S0002-9149(16)31571.
    PubMed     Text format     Abstract available


  96. CODNER P, Levi A, Gargiulo G, Praz F, et al
    Impact of Renal Dysfunction on Results of Transcatheter Aortic Valve Replacement Outcomes in a Large Multicenter Cohort.
    Am J Cardiol. 2016 Sep 15. pii: S0002-9149(16)31498.
    PubMed     Text format     Abstract available


  97. DAWOOD FZ, Judd S, Howard VJ, Limdi NA, et al
    High-Sensitivity C-Reactive Protein and Risk of Stroke in Atrial Fibrillation (from the Reasons for Geographic and Racial Differences in Stroke Study).
    Am J Cardiol. 2016 Sep 14. pii: S0002-9149(16)31476.
    PubMed     Text format     Abstract available


  98. MAKAM RC, Erskine N, McManus DD, Lessard D, et al
    Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
    Am J Cardiol. 2016 Sep 13. pii: S0002-9149(16)31472.
    PubMed     Text format     Abstract available


    August 2016
  99. LO JY, Minich LL, Tani LY, Wilkes J, et al
    Factors Associated With Resource Utilization and Coronary Artery Dilation in Refractory Kawasaki Disease (from the Pediatric Health Information System Database).
    Am J Cardiol. 2016 Aug 31. pii: S0002-9149(16)31430.
    PubMed     Text format     Abstract available


  100. THANOPOULOS BV, Ninios V, Dardas P, Giannopoulos A, et al
    Catheter Closure Through a Venous Approach of Patent Ductus Arteriosus in Small Pediatric Patients Using Combined Angiographic and Echocardiographic Guidance.
    Am J Cardiol. 2016 Aug 23. pii: S0002-9149(16)31383.
    PubMed     Text format     Abstract available


  101. TRZECIAK P, Wozakowska-Kaplon B, Niedziela J, Gierlotka M, et al
    Comparison of Inhospital and 12- and 36-Month Outcomes After Acute Coronary Syndrome in Men Versus Women <40 Years (from the PL-ACS Registry).
    Am J Cardiol. 2016 Aug 12. pii: S0002-9149(16)31337.
    PubMed     Text format     Abstract available


  102. KOHLI P, Knowles JW, Sarraju A, Waters DD, et al
    Metabolic Markers to Predict Incident Diabetes Mellitus in Statin-Treated Patients (from the Treating to New Targets and the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trials).
    Am J Cardiol. 2016 Aug 12. pii: S0002-9149(16)31324.
    PubMed     Text format     Abstract available


  103. BIAGINI E, Pazzi C, Olivotto I, Musumeci B, et al
    Usefulness of Electrocardiographic Patterns at Presentation to Predict Long-term Risk of Cardiac Death in Patients With Hypertrophic Cardiomyopathy.
    Am J Cardiol. 2016;118:432-9.
    PubMed     Text format     Abstract available


    July 2016
  104. PATEL NJ, Pau D, Nalluri N, Bhatt P, et al
    Temporal Trends, Predictors, and Outcomes of In-Hospital Gastrointestinal Bleeding Associated With Percutaneous Coronary Intervention.
    Am J Cardiol. 2016 Jul 29. pii: S0002-9149(16)31234.
    PubMed     Text format     Abstract available


  105. MURALIDHARAN A, Thiagarajan K, Van Ham R, Gleason TG, et al
    Meta-Analysis of Perioperative Stroke and Mortality in Transcatheter Aortic Valve Implantation.
    Am J Cardiol. 2016 Jul 18. pii: S0002-9149(16)31181.
    PubMed     Text format     Abstract available


  106. TAKAHASHI H, Jimbo Y, Takano H, Abe H, et al
    Intracerebral Hematoma Occurring During Warfarin Versus Non-Vitamin K Antagonist Oral Anticoagulant Therapy.
    Am J Cardiol. 2016;118:222-5.
    PubMed     Text format     Abstract available


  107. ATHER S, Shendre A, Beasley TM, Brown T, et al
    Effect of Left Ventricular Systolic Dysfunction on Response to Warfarin.
    Am J Cardiol. 2016;118:232-6.
    PubMed     Text format     Abstract available


    June 2016
  108. WONG CX, Odutayo A, Emdin CA, Kinnear NJ, et al
    Meta-Analysis of Anticoagulation Use, Stroke, Thromboembolism, Bleeding, and Mortality in Patients With Atrial Fibrillation on Dialysis.
    Am J Cardiol. 2016;117:1934-41.
    PubMed     Text format     Abstract available


  109. QUINN GR, Singer DE, Chang Y, Go AS, et al
    How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?
    Am J Cardiol. 2016 Jun 15. pii: S0002-9149(16)31035.
    PubMed     Text format     Abstract available


  110. FAUCHIER L, Lecoq C, Ancedy Y, Stamboul K, et al
    Evaluation of 5 Prognostic Scores for Prediction of Stroke, Thromboembolic and Coronary Events, All-Cause Mortality, and Major Adverse Cardiac Events in Patients With Atrial Fibrillation and Coronary Stenting.
    Am J Cardiol. 2016 Jun 14. pii: S0002-9149(16)31039.
    PubMed     Text format     Abstract available


    May 2016
  111. HANSEN GM, Egeberg A, Holmstrup P, Hansen PR, et al
    Relation of Periodontitis to Risk of Cardiovascular and All-Cause Mortality (from a Danish Nationwide Cohort Study).
    Am J Cardiol. 2016 May 30. pii: S0002-9149(16)30939.
    PubMed     Text format     Abstract available


  112. SKELDING KA, Yakubov SJ, Kleiman NS, Reardon MJ, et al
    Transcatheter Aortic Valve Replacement Versus Surgery in Women at High Risk for Surgical Aortic Valve Replacement (from the CoreValve US High Risk Pivotal Trial).
    Am J Cardiol. 2016 May 28. pii: S0002-9149(16)30954.
    PubMed     Text format     Abstract available


  113. EMDIN CA, Odutayo A, Wong CX, Tran J, et al
    Meta-Analysis of Anxiety as a Risk Factor for Cardiovascular Disease.
    Am J Cardiol. 2016 May 28. pii: S0002-9149(16)30944.
    PubMed     Text format     Abstract available


  114. FORREST JK, Adams DH, Popma JJ, Reardon MJ, et al
    Transcatheter Aortic Valve Replacement in Women Versus Men (from the US CoreValve Trials).
    Am J Cardiol. 2016 May 14. pii: S0002-9149(16)30867.
    PubMed     Text format     Abstract available


  115. SWAMINATHAN RV, Feldman DN, Pashun RA, Patil RK, et al
    Gender Differences in In-Hospital Outcomes After Coronary Artery Bypass Grafting.
    Am J Cardiol. 2016 May 14. pii: S0002-9149(16)30858.
    PubMed     Text format     Abstract available


  116. JACOBS V, May HT, Bair TL, Crandall BG, et al
    Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation.
    Am J Cardiol. 2016 May 5. pii: S0002-9149(16)30561.
    PubMed     Text format     Abstract available


  117. MOON J, Suh J, Oh PC, Lee K, et al
    Relation of Stature to Outcomes in Korean Patients Undergoing Primary Percutaneous Coronary Intervention for Acute ST-Elevation Myocardial Infarction (from the INTERSTELLAR Registry).
    Am J Cardiol. 2016 May 5. pii: S0002-9149(16)30568.
    PubMed     Text format     Abstract available


  118. HECHT EM, Arheart KL, Lee DJ, Hennekens CH, et al
    Interrelation of Cadmium, Smoking, and Cardiovascular Disease (from the National Health and Nutrition Examination Survey).
    Am J Cardiol. 2016 May 4. pii: S0002-9149(16)30560.
    PubMed     Text format     Abstract available


    April 2016
  119. PROIETTI M, Lane DA, Lip GY
    Relation of Nonvalvular Atrial Fibrillation to Body Mass Index (from the SPORTIF Trials).
    Am J Cardiol. 2016 Apr 21. pii: S0002-9149(16)30494.
    PubMed     Text format     Abstract available


  120. GOKSULUK H, Gulec S, Ozcan OU, Gerede M, et al
    Usefulness of Neuron-Specific Enolase to Detect Silent Neuronal Ischemia After Percutaneous Coronary Intervention.
    Am J Cardiol. 2016 Apr 6. pii: S0002-9149(16)30424.
    PubMed     Text format     Abstract available


    March 2016
  121. LEIGH JA, O'Neal WT, Soliman EZ
    Electrocardiographic Left Ventricular Hypertrophy as a Predictor of Cardiovascular Disease Independent of Left Ventricular Anatomy in Subjects Aged >/=65 Years.
    Am J Cardiol. 2016 Mar 19. pii: S0002-9149(16)30366.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: